CREATE Medicines
Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.
Domain
createmedicines.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$73.0M
Founded
2018
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does CREATE Medicines use?+
CREATE Medicines uses 14 technologies including Google Analytics, Google Tag Manager, Next.js.
What industry is CREATE Medicines in?+
CREATE Medicines operates in the Biotechnology industry.
Where is CREATE Medicines based?+
CREATE Medicines is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026